Fibromyalgia-Current and Future Players

Fibromyalgia-Current and Future Players

  • Products Id :- GDHC1058FPR
  • |
  • Pages: 64
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Fibromyalgia-Current and Future Players


GlobalData has released its pharma report, "Fibromyalgia-Current and Future Players". The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Fibromyalgia Market. The report identifies and analyses the key companies shaping and driving the global Fibromyalgia market. The report provides insight into the competitive Fibromyalgia landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData's team of industry experts.

*This is an on-demand report and will be delivered within 24 hrs. (excluding weekends) of the purchase.


Investigation of current and future market competition for Fibromyalgia

Competitor assessment

Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.

Strategic assessment of Fibromyalgia sector through market impact analysis, future market scenario and company analysis

Reasons To Buy

Gain a high level view of the trends shaping and driving Fibromyalgia market

Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.

Create an effective counter-strategy to gain a competitive advantage against those currently in the market

What's the next big thing in the global Fibromyalgia market landscape? Identify, understand and capitalize

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 5

2 Introduction 6

2.1 Catalyst 6

2.2 Related Reports 6

2.3 Upcoming Related Reports 7

3 Market Outlook 8

3.1 Global Markets 8

3.1.1 Forecast 8

3.1.2 Drivers and Barriers-Global Issues 12

4 Current and Future Players 13

4.1 Overview 13

4.2 Trends in Corporate Strategy 16

4.3 Company Profiles 17

4.3.1 Pfizer 17

4.3.2 Eli Lilly 20

4.3.3 Forest Laboratories (Actavis) 23

4.3.4 Daiichi Sankyo 26

4.3.5 Tonix Pharmaceuticals 29

4.3.6 Theravance Biopharma 32

5 Appendix 36

5.1 Bibliography 36

5.2 Abbreviations 46

5.3 Methodology 51

5.4 Forecasting Methodology 51

5.4.1 Diagnosed Fibromyalgia Patients 51

5.4.2 Percentage of Drug-Treated Patients 52

5.4.3 Drugs Included in Each Therapeutic Class 52

5.4.4 Launch and Patent Expiry Dates 52

5.4.5 General Pricing Assumptions 53

5.4.6 Individual Drug Assumptions 54

5.4.7 Generic Erosion 57

5.4.8 Pricing of Pipeline Agents 57

5.5 Primary Research-KOLs Interviewed for This Report 59

5.6 Primary Research-Prescriber Survey 60

5.7 About the Authors 61

5.7.1 Analyst 61

5.7.2 Therapy Area Director 61

5.7.3 Epidemiologist 62

5.7.4 Global Head of Healthcare 62

5.8 About GlobalData 63

5.9 Disclaimer 63

1.2 List of Figures

Figure 1: Global Sales for Fibromyalgia by Region, 2013-2023 11

Figure 2: Global Sales of Branded Products for Fibromyalgia by Company, 2013-2023 15

Figure 3: Company Portfolio Gap Analysis in Fibromyalgia, 2013-2023 16

Figure 4: Pfizer's SWOT Analysis in Fibromyalgia, 2013-2023 20

Figure 5: Eli Lilly SWOT Analysis in Fibromyalgia, 2013-2023 23

Figure 6: Forest Laboratories (Actavis) SWOT Analysis in Fibromyalgia, 2013-2023 26

Figure 7: Daiichi Sankyo SWOT Analysis in Fibromyalgia, 2013-2023 29

Figure 8: Tonix Pharmaceuticals SWOT Analysis in Fibromyalgia, 2013-2023 32

Figure 9: Theravance Biopharma SWOT Analysis in Fibromyalgia, 2013-2023 35

1.1 List of Tables

Table 1: Global Sales Forecasts (USD m) for Fibromyalgia, 2013-2023 10

Table 2: Global Fibromyalgia Market-Drivers and Barriers, 2013-2023 12

Table 3: Key Companies in the Fibromyalgia Market in the 7MM, 2014 14

Table 4: Pfizer's Fibromyalgia Portfolio Assessment, 2014 18

Table 5: Eli Lilly's Fibromyalgia Portfolio Assessment, 2014 21

Table 6: Forest Laboratories' (Actavis) Fibromyalgia Portfolio Assessment, 2014 24

Table 7: Daiichi Sankyo's Fibromyalgia Portfolio Assessment, 2014 27

Table 8: Tonix Pharmaceutical's Fibromyalgia Portfolio Assessment, 2014 30

Table 9: Theravance Biopharma's Fibromyalgia Portfolio Assessment, 2014 33

Table 10: Key Launch Dates for Fibromyalgia Drugs in the 7MM 52

Table 11: Key Patent Expiries for the Marketed Drugs Indicated for Fibromyalgia 53

Table 12: High-Prescribing Physicians (Non-KOLs) Surveyed, by Country 60

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]


Eli Lilly

Forest Laboratories (Actavis)

Daiichi Sankyo

Tonix Pharmaceuticals

Theravance Biopharma

select a license

Single User License
USD 2995 INR 202013
Site License
USD 5990 INR 404026
Corporate User License
USD 8985 INR 606038



Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]